Carson Wealth (CWM LLC)’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27K Buy
38,500
+31,671
+464% +$29.6K ﹤0.01% 4239
2025
Q4
$11K Sell
6,829
-4,964
-42% -$7.93K ﹤0.01% 4503
2025
Q3
$19K Sell
11,793
-339
-3% -$589 ﹤0.01% 4159
2025
Q2
$26K Buy
12,132
+5,836
+93% +$14.1K ﹤0.01% 3744
2025
Q1
$17K Buy
6,296
+4,760
+310% +$18.8K ﹤0.01% 3804
2024
Q4
$6K Buy
1,536
+1,453
+1,751% +$5.49K ﹤0.01% 4132
2024
Q3
$0 Buy
83
+12
+17% +$51 ﹤0.01% 5030
2024
Q2
$0 Buy
71
+67
+1,675% +$288 ﹤0.01% 4809
2024
Q1
$0 Buy
+4
New +$19 ﹤0.01% 4585
2023
Q3
Sell
-33
Closed 4403
2023
Q2
$0 Hold
33
﹤0.01% 4366
2023
Q1
$0 Hold
33
﹤0.01% 4245
2022
Q4
$0 Hold
33
﹤0.01% 4146
2022
Q3
$0 Hold
33
﹤0.01% 4094
2022
Q2
$0 Buy
+33
New +$163 ﹤0.01% 3996

Other funds holding MXCT

Carson Wealth (CWM LLC)'s MXCT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its MaxCyte (MXCT) stake by 464% in Q1 2026, buying an estimated $29.6K and bringing the position to 38,500 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #4239.

Carson Wealth (CWM LLC) first reported a position in MXCT in Q2 2022 and has held it in 14 quarters since. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Carson Wealth (CWM LLC) held 38,500 shares of MaxCyte worth $27K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 31,671 MaxCyte shares in Q1 2026, an estimated $29.6K.
  • MaxCyte made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4239 holding.
  • Carson Wealth (CWM LLC) first reported a position in MaxCyte in Q2 2022 and has held it in 14 quarters since.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.